SS
DRTS icon

SBI Securities’s Alpha Tau Medical DRTS Stock Holding History

SBI Securities’s Portfolio DRTS Stock Details DRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1
Closed -$5 – 4081
2025
Q3 		$5 Buy
+1
New +$3 ﹤0.01% 4101
2025
Q1 		– Sell
-10
Closed -$31 – 4150
2024
Q4 		$31 Buy
+10
New +$26 ﹤0.01% 3740

Other funds holding DRTS

HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
AC
Apella Capital West Hartford, Connecticut $7.08B AUM 17.38% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.49B AUM 30.44% 1-Year Est. Return
Kovitz Investment Group Partners
Kovitz Investment Group Partners Chicago, Illinois $4.31B AUM 20.41% 1-Year Est. Return
DSC
Daytona Street Capital Saint Louis, Missouri $130M AUM
GIA
Gem Investment Advisors Teaneck, New Jersey $102M AUM
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SAM
Satovsky Asset Management New York $566M AUM 15.8% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return

SBI Securities's DRTS Position: Q4 2025 in Review

SBI Securities sold out of Alpha Tau Medical (DRTS) in Q4 2025, closing a stake of 1 share — an estimated $5 sold.

SBI Securities first reported a position in DRTS in Q4 2024 and held it in 2 quarters. The position peaked at $31 in Q4 2024. 35 funds tracked by Wall St. Rank hold DRTS as of Q4 2025.

  • SBI Securities reported no remaining Alpha Tau Medical position as of Q4 2025 after selling out during the quarter.
  • SBI Securities sold 1 Alpha Tau Medical share in Q4 2025, an estimated $5.
  • SBI Securities first reported a position in Alpha Tau Medical in Q4 2024 and held it in 2 quarters.
  • SBI Securities's Alpha Tau Medical position peaked at $31 in Q4 2024.
  • 35 funds tracked by Wall St. Rank held Alpha Tau Medical as of Q4 2025.

Based on SBI Securities's 13F filing for Q4 2025, filed 3 Feb 2026.